Eleanor Thompson AstraZeneca, the British-Swedish pharmaceutical company, has recently initiated the global withdrawal of its Covid-19 vaccine, Vaxzevria, citing safety issues and a surplus of newer vaccines. Here are the key points:
- Safety Concerns:
- AstraZeneca’s decision comes after the company admitted that its Covid vaccines can cause a rare but serious side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) in very rare cases1. TTS is characterized by blood clots (thrombosis) and low platelet counts (thrombocytopenia).
- Although the vaccine was found to be safe and effective overall, the risk of TTS led to its withdrawal from the market.
- Surplus of Newer Vaccines:
- A variety of newer vaccines have become available, specifically adapted to target Covid-19 variants.
- The availability of these updated vaccines has led to a decline in demand for the AstraZeneca vaccine, which is no longer being manufactured or supplied2.
- Other countries had already stopped supplying the AstraZeneca vaccine due to the widespread availability of newer alternatives.
- Global Impact:
- AstraZeneca’s vaccine played a pivotal role in the early days of the pandemic when limited vaccines were available. Over 6.5 million lives were estimated to have been saved in the first year of its use, with over 3 billion doses supplied globally2.
- However, the safety concerns and the availability of newer vaccines have prompted its withdrawal worldwide.
- Vaccine Details:
- Vaxzevria (formerly known as the AstraZeneca Covid vaccine) was authorized for use in those aged 18 and older.
- It was administered as two injections, usually into the muscle of the upper arm, about three months apart.
- Vaxzevria is made from another virus of the adenovirus family, modified to contain the gene for making a protein from SARS-CoV-2, the virus that causes Covid-19. Importantly, it does not contain the virus itself and cannot cause the disease.
- Conclusion:
- AstraZeneca will work with regulators and partners to conclude this chapter and continue its significant contribution to the fight against the Covid-19 pandemic2.
- The withdrawal of the AstraZeneca vaccine underscores the importance of ongoing vaccine research and development to address safety concerns and adapt to emerging variants.
In summary, AstraZeneca’s decision to withdraw its Covid-19 vaccine reflects the evolving landscape of vaccine availability and safety considerations. While the vaccine played a crucial role, newer alternatives have taken its place, and safety remains a top priority in the global fight against the pandemic3.
